Database lock dates slip when planning starts at the last patient's last visit. The sponsors who hit their readout dates work backward from the topline date, identifying every activity between last visit and results, assigning owners and durations, and starting the long-lead work, such as data cleaning, external data reconciliation and analysis planning, months before the study ends. A lock plan is a critical path, not a checklist.
Why does database lock slip?
Data entry and query backlogs accumulate during the study. External data from laboratories and other vendors arrive late or don't reconcile. Coding is incomplete. Safety and clinical databases don't match. The statistical analysis plan isn't final. Reviews are scheduled late, with key people unavailable. And small issues that were tolerable mid-study become blockers at the end.
What sits between last visit and topline?
Final data entry and query resolution.
Reconciliation of external data, such as central laboratory, imaging, ECG and pharmacokinetic data.
Reconciliation of serious adverse events between the safety and clinical databases.
Medical coding of adverse events, medical history and medications.
Review of protocol deviations and decisions on analysis populations.
Data review meetings and, for blinded studies, a blind data review.
Final approval of the statistical analysis plan before unblinding.
Database lock, unblinding and production of topline tables, listings and figures.
Quality checks and interpretation.
How do you build the plan backward?
Start with the target topline date. Estimate the time for analysis and quality checks, then for lock and unblinding, then for final reviews, then for cleaning and reconciliation after the last visit. Identify dependencies and the critical path. Add realistic buffers. Then compare the resulting last-visit-to-topline duration with what has been promised to the board. If they don't match, change the plan now, not in the final month.
Which work should start early?
Ongoing cleaning, so the backlog at last visit is small. Regular external data reconciliation throughout the study. Continuous coding. Periodic serious adverse event reconciliation. Drafting and finalizing the statistical analysis plan well before unblinding. Programming and validating analysis outputs on blinded or dummy data. Each of these can remove weeks from the end of the study.
What should the sponsor monitor?
Outstanding queries and their age, missing pages, external data reconciliation status, coding completion, open deviation decisions and the status of the statistical analysis plan. Review these monthly in governance, and weekly in the final months. Trends tell you early whether the lock date is realistic.
Who needs to be available?
The medical monitor, biostatistician, data manager, clinical operations lead and, for blinded reviews, the right reviewers. Schedule key reviews and approvals months in advance. Many lock delays come down to a reviewer on vacation at exactly the wrong time.
How do data standards help?
Collecting data using standards that map cleanly to submission formats reduces conversion work at the end and lowers the risk of last-minute surprises. Sponsors who defer standards until a submission often pay for it in time at the moment they can least afford it.
Keep reading: CDISC From Day One: Why Small Sponsors Pay Later
